ORTEXORTEX News
Tracking EMR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EM
Earnings PreviewEMR

Emerson Electric Faces Divided Analyst Opinion Before Wednesday Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 1 Nov 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Emerson Electric reports its latest quarterly results on Wednesday, with the stock at $164.94 after a 3.4% drop on Friday that trimmed a stronger month.

The analyst community is notably split ahead of the release. Morgan Stanley's Chris Snyder raised his target to $145 on October 19 while holding an Underweight rating, a level well below where the stock is trading. That sits alongside Outperform ratings from Mizuho, RBC Capital, and Bernstein, all of whom lifted targets into the $180 to $188 range over the same period. JPMorgan moved to $184 on October 9, also Overweight. The gap captures the core disagreement: bulls point to Emerson's shift toward industrial automation, its Project Beyond initiative targeting two-thirds recurring software revenue, and expected organic growth of 4 to 7% annually. Bears focus on competitive pressures, the complexity of its global operations, and the valuation that the bull case demands. The PE multiple runs at about 20.9x, with EV/EBITDA at 16.8x.

Forward earnings momentum argues for the optimists. Emerson's factor score for 12-month forward EPS year-on-year growth ranks in the 97th percentile, and both 30-day and 90-day EPS momentum scores rank in the 80s and 90s, meaning analysts have been revising estimates sharply higher. The short score of 34.8 is unremarkable. Short interest at 1.8% of the free float has crept up roughly 17% over the past month in share terms, but remains a low absolute level, and the lending market is relaxed: availability is nearly 1,800% of short interest, meaning shares to borrow are effectively unconstrained. Cost to borrow is 0.56%, trivial. There is no short-side pressure of note.

Options positioning is mildly more defensive than the recent baseline, but not dramatically so. The put/call ratio at 0.50 is less than a standard deviation above its 20-day average of 0.48, and the reading is toward the middle of its 52-week range. That implies no particular anxiety about the print from the derivatives market. Peers had a rougher Friday: AME fell 4.2%, ETN fell 6.0%, and PLPC dropped over 9%, making Emerson's 3.4% decline look relatively contained. Over the week, Emerson's 2.1% gain compares to a peer median in negative territory.

On the insider side, CEO Karsanbhai Lanca sold roughly $1.6 million of stock in August at around $162, outside any 10b5-1 plan. The COO sold $1.6 million in June. Neither trade is alarming in scale relative to Emerson's $92 billion market cap, but the net 90-day flow runs negative at about $4.4 million, with no open-market purchases on the register. Wednesday's print will test whether the acceleration in forward earnings revisions holds, and whether management's automation-led margin story remains intact at a valuation the bears already consider stretched.

Stocks in this article

See the live data behind this article on ORTEX.

Open EMR on ORTEX →

How this article was generated

Generated
1 Nov 2026, 04:10
Data as of
1 Nov 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.